CASP9 Target Analysis Report Summary
About the Target
Based on the given context information, here are key viewpoints regarding the role of CASP9:
In resistant hiPSC, overexpressed BCL2 inhibits the activation of CASP9 and fails to induce complete apoptosis [1].
Activation of CASP9 is involved in MLL-induced programmed cell death (anoikis) in MCF-7 cells [2].
Inhibition of CASP3 signaling pathway by MeCP2 promotes gastric cancer (GC) cell proliferation and inhibits apoptosis [3].
Overexpression of TFF3 in prostate tumors activates the PI3K/AKT pathway, blocking the mitochondria-induced apoptotic pathway, and CASP9 activation [4].
OASL knockdown leads to lower expression of CASP9 in chicken fibroblast cells infected with Newcastle disease virus (NDV) [5].
Summary:
The role of CASP9 in apoptosis has been studied in various contexts. In resistant hiPSC and prostate tumors, overexpression of anti-apoptotic proteins (BCL2 and TFF3, respectively) hinders CASP9 activation and inhibits programmed cell death. Conversely, in MCF-7 cells and chicken fibroblast cells infected with NDV, CASP9 is involved in inducing programmed cell death. In gastric cancer, MeCP2 inhibits apoptosis by suppressing the CASP3 signaling pathway. Overall, CASP9 appears to play a critical role in regulating apoptotic pathways in different cellular contexts. [1][2][3][4][5]
Figure [1]
Figure [2]
Figure [3]
Figure [4]
Figure [5]
Note: If you are interested in the full version of this target analysis report, or if you'd like to learn how our AI-powered BDE-Chem can design therapeutic molecules to interact with the CASP9 target at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai.
More Common Targets
ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BECN1 | BRAF | BRCA1 | CAMP | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CD8A | CDH1 | CDKN1A | CDKN2A | CREB1 | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | EREG | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA4 | HSPA5 | IDO1 | IFNA1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MDM2 | MET | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SLTM | SMAD4 | SOD1 | SQSTM1 | SRC | STAT1 | STAT3 | STAT5A | TAK1 | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1
